Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
amgen
clinical trials
deals
new york blog main
new york top stories
novartis
abbvie
adverum biotechnologies
albert bourla
alirocumab
ally bridge group
alnylam pharmaceuticals
alzheimer's disease
amicus therapeutics
arvinas
batten disease
bayer
big data analytics
biogen
blackrock
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casdin capital
casimir trials
celenex
christine mcsherry
chuck schumer
clinial trials
crispr therapeutics
What
company
3
×
drug
3
×
bio
medicines
new
acquire
acquisitions
agreed
albert
analysis
biggest
billion
biotech
bourla
bring
brings
cash
ceo
cholesterol
compound
crispr
deal
develop
diseases
employing
fda
future
genetic
goldfinch
imports
ipo
kidney
later
lead
maker
maps
measured
medco
million
novartis
Language
unset
unknown
Current search:
drug
×
company
×
" national top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
